🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Objectives: Phase I part * Primary Objective: To determine the recommende...
Status
Terminated
Location
China Medical University Hospital
Start Date
2012-07
Trial ID
NCT01658358
A study to compare the safety and efficacy of an aromatase inhibitor in com...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-05-05
Trial ID
NCT01160211
Treatments Being Tested
The objective of this phase I/ II study is therefore to assess the safety a...
Status
Completed
Location
Centre Georges François Leclerc
Start Date
2008-11
Trial ID
NCT01044485
The purpose of this study is to determine the efficacy and safety of an ora...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-01
Trial ID
NCT00075270
Treatments Being Tested
Background: \- The current standard of care for advanced lung cancer and c...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2011-02-08
Trial ID
NCT01306045
Target Population: female patients with HER2-negative, ER and/or PgR positi...
Status
Terminated
Location
Cliniche Gavazzeni S.p.A. - Humanitas Gavazzeni
Start Date
2011-11
Trial ID
NCT01477060
This study evaluated and compared the efficacy and tolerability of lapatini...
Status
Completed
Location
Novartis Investigative Site
Start Date
2003-12-09
Trial ID
NCT00073528
This study was designed to determine how effective and safe a new investiga...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-03
Trial ID
NCT00105950
Treatments Being Tested
This study is being conducted to compare the efficacy and safety of pazopan...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-07
Trial ID
NCT00347919
Neoadjuvant chemotherapy has become the standard of care for breast cancer ...
Status
Withdrawn
Location
UNM CRTC
Start Date
2023-07-31
Trial ID
NCT00455039
Treatments Being Tested